Natco Pharma has secured a crucial regulatory milestone with its Kothur manufacturing facility receiving clearance from the United States Food and Drug Administration (USFDA). This development underscores the company’s compliance with stringent international quality standards and strengthens its prospects in the highly regulated U.S. pharmaceutical market. The approval is expected to enhance Natco Pharma’s export capabilities, broaden its product pipeline, and support long-term growth.